Measuring additive interaction using odds ratios.

Epidemiologic Perspectives & Innovations : EP+I
Linda Kalilani, Julius Atashili

Abstract

Interaction measured on the additive scale has been argued to be better correlated with biologic interaction than when measured on the multiplicative scale. Measures of interaction on the additive scale have been developed using risk ratios. However, in studies that use odds ratios as the sole measure of effect, the calculation of these measures of additive interaction is usually performed by directly substituting odds ratios for risk ratios. Yet assessing additive interaction based on replacing risk ratios by odds ratios in formulas that were derived using the former may be erroneous. In this paper, we evaluate the extent to which three measures of additive interaction - the interaction contrast ratio (ICR), the attributable proportion due to interaction (AP), and the synergy index (S), estimated using odds ratios versus using risk ratios differ as the incidence of the outcome of interest increases in the source population and/or as the magnitude of interaction increases. Our analysis shows that the difference between the two depends on the measure of interaction used, the type of interaction present, and the baseline incidence of the outcome. Substituting odds ratios for risk ratios, when calculating measures of additive inte...Continue Reading

References

Nov 4, 1992·Journal of the National Cancer Institute·J A TaylorE Liu
Jan 1, 1991·Journal of Clinical Epidemiology·W D Thompson
Apr 1, 1988·Scandinavian Journal of Work, Environment & Health·S Greenland, C Poole
Apr 1, 1997·American Journal of Epidemiology·J Darroch
Feb 1, 1997·International Journal of Epidemiology·C ZocchettiP A Bertazzi
Jul 1, 1997·Journal of Clinical Epidemiology·A MorabiaJ R Landis
Apr 29, 1998·BMJ : British Medical Journal·H T DaviesM Tavakoli
Feb 13, 2001·Carcinogenesis·A F OlshanD A Bell
Mar 30, 2002·BMJ : British Medical Journal·Rosalind M GreenAshley Woodcock
Jul 29, 2003·American Journal of Epidemiology·Anders Skrondal
Jun 16, 2004·Circulation·Luis A García RodríguezAntonio González-Pérez
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Chien-Hung LeeMing-Tsang Wu
Mar 5, 2005·Epidemiologic Perspectives & Innovations : EP+I·Ulka B CampbellSharon Schwartz
Apr 7, 2005·Environmental Health Perspectives·Russ HauserAntonia M Calafat
Aug 27, 2005·European Journal of Epidemiology·Anders Ahlbom, Lars Alfredsson

❮ Previous
Next ❯

Citations

Sep 23, 2006·The Journal of Infectious Diseases·Adamson S Muula
Jun 27, 2009·Neuropsychiatric Disease and Treatment·Huai-Rong LuoMa-Li Wong
Jan 24, 2013·Journal of Clinical Biochemistry and Nutrition·Nobuyuki ToshikuniMikihiro Tsutsumi
Feb 20, 2009·American Journal of Epidemiology·Na WangQingwu Jiang
Feb 5, 2009·Kidney International·Renée de MutsertFriedo W Dekker
Jun 5, 2008·PLoS Neglected Tropical Diseases·Amara E EzeamamaJennifer F Friedman
Nov 29, 2011·Journal of Affective Disorders·Bauke T StegengaMirjam I Geerlings
Oct 21, 2016·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Laura WellsViveca Östberg
Jul 6, 2017·Metabolic Syndrome and Related Disorders·Naeimeh HosseiniNizal Sarrafzadegan
Feb 15, 2018·Occupational Medicine·J HermanssonK Gillander Gådin
Jun 25, 2015·Journal of Diabetes and Metabolic Disorders·Paul D Loprinzi, Jerome F Walker
Mar 16, 2018·Stroke; a Journal of Cerebral Circulation·Charlotte ZernaShelagh B Coutts
Jan 14, 2011·Epidemiology·Haitao ChuStephen R Cole
Jun 5, 2018·Journal of the Chinese Medical Association : JCMA·Yih-Ru ChenHung-Yi Chiou
Aug 11, 2010·International Archives of Occupational and Environmental Health·Jesper KristiansenJonas Ardö
Apr 25, 2013·Annals of the Rheumatic Diseases·Camilla BengtssonSaedis Saevarsdottir
Jun 26, 2014·Alcoholism, Clinical and Experimental Research·June H KimDeborah S Hasin
Mar 10, 2010·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Yue ChenHeidi Liepold
Mar 16, 2019·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Claudia StoicescuMietta Mahanani

❮ Previous
Next ❯

Software Mentioned

SAS

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.